Organon

Our mission is to deliver impactful medicines and solutions for a healthier every day. We reserve the right to remove any comments that reference a product.

Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. For more information, visit www.organon.com.

Commenting Guidelines:

Thank you for your interest in Organon. Providing useful and interesting content about our company and fostering open and

respectful dialogue around specific topics is our ultimate goal. Organon respects the rights of individuals using social media to voice their views and opinions. However, within our social media channels, we reserve the right to remove comments that are considered inappropriate, off-topic, abusive, or being used to promote and solicit for third-party sites, initiatives or products. We ask that you please respect the following guidelines for our page:

Please refrain from mentioning Organon products or products from other companies. Comments or posts that are factually inaccurate or misleading, are spam, inappropriate, violate another’s copyright or intellectual property, use profanity or are defamatory will be deleted. There may be other circumstances that will require us to remove a comment. Organon reserves the right to delete any posting at its sole discretion. We encourage you to respect fellow community members and follow Facebook's Statements of Rights and Responsibilities. This page is intended to provide a forum for open discussion and the content provided by those other than Organon does not represent the opinions or positions of Organon. The content available on this page is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Organon recommends that you consult your healthcare provider regarding personal health matters. Privacy:

Organon may collect information about you, such as your name and/or user name and the comments you post to understand and address perspectives about our company mission, strategy, practices, developments within our business and in healthcare and for legal and regulatory purposes. For more information about Organon's privacy practices, please read our Privacy Commitment at www.organon.com/privacy.

05/15/2026

Migraine is often invisible. Its impact is not – especially for women.

For many women living with migraine, the impact can be profound and may vary across different life stages as migraine is a condition that may be intertwined with a woman’s hormonal health across various life stages – from puberty and menstrual cycles to pregnancy, contraception, and menopause.

This may then lead to missed days and reduced participation in social, personal and daily activities, affecting careers, relationships, and mental health.

All while continuing to face stigma, delayed diagnosis, or barriers to care.

At Organon, we’re committed globally to helping raise awareness on the impact to women’s health and support greater understanding of migraine care options.

Because feeling seen, heard, and supported matters.

05/13/2026

For Earth Month 2026, Organon celebrated a meaningful sustainability milestone:
🌱 Thanks to our founders’ participation in Earth Day activities since 2023, our global Earth Day program planted 12,446 trees–one for every activity completed.

We began April with 9,142 trees planted between 2023 and 2025. Thanks to the continued engagement of our founders around the world, 3,304 will be planted in 2026, surpassing the 10,000‑tree mark—a clear, measurable achievement built on years of consistent action.

Our Earth Day forests, created in collaboration with Natuurpunt near our Heist manufacturing site in Belgium, contribute to long‑term ecosystem restoration and locally protected biodiversity. Open to the public and clearly signposted, they connect our environmental commitments to something real, visible, and lasting.

A healthier planet supports healthier communities—and each tree brings us closer to a more sustainable future for women, their families, economies, and society.

05/10/2026

Mothers don't just nurture - they take charge of healthcare decisions. According to the U.S. Department of Labor, mothers make approximately 80% of healthcare decisions for their families.

Organon seeks to build a healthcare ecosystem that empowers and supports all mothers as they serve this critical role in their families and communities. This , we gratefully acknowledge mothers everywhere and are steadfast in our commitment to support their health.

04/29/2026

We’re honored to join the American College of Obstetricians & Gynecologists - ACOG in Washington, DC, as it celebrates its 75th anniversary.

Our presence focuses on women’s stories and supporting expanded access to appropriate contraceptive options, including long-acting options, for women at different stages of their reproductive lives and across women with varying body mass indices.

📍 Visit us at booths #933 and #849

🗓️Marking another year at this important meeting, we’re presenting recent data highlighting a Phase 3, multicenter, open label study evaluating extended use of our long-acting contraceptive option. Join us for our poster session on May 2, 8:00–9:00 AM ET in Hall DE.

We’re proud to gather with the healthcare community at , including as a presenting sponsor of the Anniversary Gala.

Intended for US audiences only.

04/23/2026

Prioritizing health can happen in phases. A KFF Women’s Health Survey published in 2021 found that while more than 93% of women had seen a health care provider in the past two years, only 73% had a general check-up or well-woman visit.

A well-woman visit is an opportunity to check in, ask questions, and better understand your overall health. Many definitions reduce women’s health needs to only reproductive health, but a well-woman visit goes beyond this. It’s a whole-health appointment aimed at managing your physical and mental health, discussing lifestyle choices, and more.

At Organon, we’re committed to supporting women through every phase of their health journey—helping ensure they have the information, confidence, and resources they need to have meaningful conversations with their doctors and get the answers and treatments they deserve.

04/21/2026

During National Infertility Awareness Week, we’re uniting together around the theme — because infertility doesn’t have one face, one story, or one path. It can affect anyone, regardless of race, religion, sexuality, or economic status.

The is often filled with highs, lows, and countless “what ifs” – and no one should have to navigate it alone.

At Organon, we’re proud of our long‑standing relationship with RESOLVE: The National Infertility Association and to be part of a powerful movement dedicated to reducing stigma, expanding reproductive health education, and empowering those impacted by infertility.

is a moment to speak up, listen closely and advance conversations. Together, we’re helping remove the barriers to family building — and supporting the journey, at every stage, across all income levels 🧡

04/17/2026

affects women disproportionately with more than 100 autoimmune conditions impacting women much more than men. For young and middle‑aged women, these diseases collectively are among the leading causes of death in the U.S. – yet they remain largely overlooked.

70% of people who suffer from rheumatoid arthritis are women, and they face a heightened risk of flare after childbirth, highlighting the need for more tailored care during life’s most vulnerable phases.

Advancing biosimilar adoption requires collaboration across policy, market access, R&D, public health bodies, and regulators. At Organon, we’re working together to ensure patients and prescribers understand the vital role biosimilars can play for those living with autoimmune disease.

Find out more here: https://ogn.llc/6185v6z8v

04/09/2026

Not all symptoms are loud. Some are quiet—and often overlooked. In our new series, Quiet Symptoms, we’re shining a light on the experiences people living with chronic conditions may feel but don’t always talk about.

Migraine is the leading cause of disability among women aged 15-49, and it’s more than a bad headache. Symptoms like allodynia can show up more quietly—yet have a powerful impact. As a migraine attack builds, the nervous system can become extra sensitive, turning everyday touch into pain. Brushing your hair, taking out an earring, even wearing glasses may suddenly hurt. Often misunderstood or dismissed, allodynia can go unrecognized—but it’s an important signal that a migraine may be progressing and that care may need to be revisited.

By raising awareness of these quieter symptoms, we can help people better understand their experiences, have more informed conversations with their doctors, and take steps toward improved care.

If you’re noticing symptoms like these, speak openly with a doctor about your experience, including patterns in your migraine days, to explore preventive treatment options and help get ahead of chronic migraine.

04/07/2026

Organon was created to address the unmet needs in women’s health – and on , we’re reinforcing our commitment to deliver impactful medicines and solutions for a healthier every day.

Here are some ways we’re turning commitment into impact:

- Strengthening the evidence base by expanding and incorporating real‑world data across our portfolio, including in dermatology and contraception

- Leveraging our global footprint to accelerate product registration and launches through our integrated commercial, manufacturing, and research and development teams

- Supporting the next generation of breakthroughs through programs like the Organon Accelerator Program, which helps innovators in gynecological conditions, maternal health, contraception, and menopause by lending our scientific expertise to drive real world impact

- Educating and myth‑busting on women’s health topics – meeting women on their preferred channels with data, science, expert insights, and real‑world evidence to counter misinformation

Progress in women’s health is intentional – grounded in science, strengthened by collaboration, and driven by purpose.

04/02/2026

On March 8, we joined millions in recognizing — a moment to honor the strength and resilience of women everywhere, including those who shape Organon. This year, the day arrived as many continue to navigate the heaviness of the world and uncertain realities.

As part of our commitment to our founders, we continue to provide dedicated time for them to pause, reflect, and care for themselves.

See how our teams recognized this important day.

Organon Korea held their annual ‘Walk for Her Health’ initiative that inspires daily wellness habits and raises awareness of women’s health. Approximately 10,000 participants (founders and external) have donated their steps, which were converted into meaningful support for underserved women’s health communities.

Organon Japan once again participated in the White Ribbon Charity Run, an event organized by JOICFP, a Japan-based international NGO dedicated to women’s health and SRHR. This year, more than 30 Founders from our Tokyo office participated, standing in solidarity with women and girls. The 2026 event spans a record 62 locations across Japan, bringing together approximately 6,000 charity runners nationwide.

Organon LATAM joined the global campaign by amplifying women’s voices and reinforcing our commitment to equity in women’s health. Our founders across the region united under the concept, “Tus sueños salen a la cancha a ganar,” and engaged through participative storytelling and content centered on wellbeing, self‑care, and collective impact. Across Mexico, Argentina, and Colombia, we highlighted the structural gaps that delay timely diagnosis and care for women, positioning Organon as an advocate for informed, equitable health decisions.

Organon Russia held a mix of in person and virtual workshops. One focused on interactive storytelling and visual metaphors to spark reflection and problem-solving, while the other blended goal setting and writing exercises to encourage growth and wellbeing.

Organon Northwest Europe participated in a panel hosted by RAISE focused on the persistent gaps in women’s health: from fundamental research to the role of pharma in the broader ecosystem and, most importantly, how we can foster deeper collaboration at every level to help close it.

Organon META (Middle East, Turkey & Africa) spotlighted women from across the region, sharing their personal and professional journeys, the many roles they navigate, and the impact while remaining committed to advancing women’s health.

03/31/2026

Last week, the Organon Dermatology cross‑functional team came together in Denver for the American Academy of Dermatology (AAD) Annual Meeting.

Following lift‑off on Friday 🚀, the days moved at light speed with a full agenda – sharing new analysis of Phase 3 data, launching a new campaign, connecting with health care providers, and engaging in meaningful discussions with advocacy partners, including Global Parents for Eczema Research, National Psoriasis Foundation, and National Eczema Association.

Across every conversation and connection point, one shared commitment stood out: how can we do more to help people living with and access the care and treatments they need?

We’re extremely proud to be part of such a dedicated community and look forward to continued collaboration as we collectively work to advance real-world data and research, education, and programs that support both patients and providers.

Address

30 Hudson Street
Jersey City, NJ
07302

Website

http://www.organon.com/

Alerts

Be the first to know and let us send you an email when Organon posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Organon:

Shortcuts

Want your practice to be the top-listed Clinic in Jersey City?